ID   MAT2B_HUMAN             Reviewed;         334 AA.
AC   Q9NZL9; B2R5Y6; Q1WAI7; Q27J92; Q3LIE8; Q567T7; Q6NYC7; Q9BS89;
AC   Q9H3E1; Q9UJ54;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 138.
DE   RecName: Full=Methionine adenosyltransferase 2 subunit beta;
DE   AltName: Full=Methionine adenosyltransferase II beta;
DE            Short=MAT II beta;
DE   AltName: Full=Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase;
GN   Name=MAT2B; Synonyms=TGR;
GN   ORFNames=MSTP045, Nbla02999, UNQ2435/PRO4995;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 2-20 AND
RP   240-257, SUBUNIT, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10644686; DOI=10.1074/jbc.275.4.2359;
RA   LeGros H.L., Halim A.-B., Geller A.M., Kotb M.;
RT   "Cloning, expression, and functional characterization of the beta
RT   regulatory subunit of human methionine adenosyltransferase (MAT II).";
RL   J. Biol. Chem. 275:2359-2366(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Sturla L., Zanardi D., Bisso A., Damonte G., Fasano M., De Flora A.,
RA   Tonetti M.;
RT   "Occurrence of a novel metabolic pathway converting dTDP-D-glucose in
RT   human cells.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5).
RA   Yang H., Magilnick N., Lu S.C.;
RT   "Alternative splicing of the MAT2B gene.";
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Neuroblastoma;
RX   PubMed=12880961; DOI=10.1016/S0304-3835(03)00085-5;
RA   Ohira M., Morohashi A., Nakamura Y., Isogai E., Furuya K., Hamano S.,
RA   Machida T., Aoyama M., Fukumura M., Miyazaki K., Suzuki Y., Sugano S.,
RA   Hirato J., Nakagawara A.;
RT   "Neuroblastoma oligo-capping cDNA project: toward the understanding of
RT   the genesis and biology of neuroblastoma.";
RL   Cancer Lett. 197:63-68(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-293.
RC   TISSUE=Pancreas, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-334.
RC   TISSUE=Heart;
RA   Liu B., Liu Y.Q., Wang X.Y., Zhao B., Sheng H., Zhao X.W., Liu S.,
RA   Xu Y.Y., Ye J., Song L., Gao Y., Zhang C.L., Zhang J., Wei Y.J.,
RA   Cao H.Q., Zhao Y., Liu L.S., Ding J.F., Gao R.L., Wu Q.Y., Qiang B.Q.,
RA   Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=11337507; DOI=10.1074/jbc.M102816200;
RA   LeGros L., Halim A.-B., Chamberlin M.E., Geller A., Kotb M.;
RT   "Regulation of the human MAT2B gene encoding the regulatory beta
RT   subunit of methionine adenosyltransferase, MAT II.";
RL   J. Biol. Chem. 276:24918-24924(2001).
RN   [12]
RP   EXPRESSION IN HEPATOMA.
RX   PubMed=12671891; DOI=10.1053/gast.2003.50151;
RA   Martinez-Chantar M.L., Garcia-Trevijano E.R., Latasa M.U.,
RA   Martin-Duce A., Fortes P., Caballeria J., Avila M.A., Mato J.M.;
RT   "Methionine adenosyltransferase II beta subunit gene expression
RT   provides a proliferative advantage in human hepatoma.";
RL   Gastroenterology 124:940-948(2003).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION, SUBUNIT, NADP-BINDING, AND PATHWAY.
RX   PubMed=23189196; DOI=10.1371/journal.pone.0050329;
RA   Gonzalez B., Garrido F., Ortega R., Martinez-Julvez M.,
RA   Revilla-Guarinos A., Perez-Pertejo Y., Velazquez-Campoy A.,
RA   Sanz-Aparicio J., Pajares M.A.;
RT   "NADP+ binding to the regulatory subunit of methionine
RT   adenosyltransferase II increases intersubunit binding affinity in the
RT   hetero-trimer.";
RL   PLoS ONE 7:E50329-E50329(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-309, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18] {ECO:0000244|PDB:2YDX, ECO:0000244|PDB:2YDY}
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 28-334 IN COMPLEX WITH NADP,
RP   AND FUNCTION.
RX   PubMed=23425511; DOI=10.1042/BJ20121580;
RA   Shafqat N., Muniz J.R., Pilka E.S., Papagrigoriou E., von Delft F.,
RA   Oppermann U., Yue W.W.;
RT   "Insight into S-adenosylmethionine biosynthesis from the crystal
RT   structures of the human methionine adenosyltransferase catalytic and
RT   regulatory subunits.";
RL   Biochem. J. 452:27-36(2013).
RN   [19] {ECO:0000244|PDB:4KTT, ECO:0000244|PDB:4KTV, ECO:0000244|PDB:4NDN}
RP   X-RAY CRYSTALLOGRAPHY (2.34 ANGSTROMS) OF 22-334 IN COMPLEX WITH
RP   MAT2A, SUBUNIT, REGION, FUNCTION, AND PATHWAY.
RX   PubMed=25075345; DOI=10.1107/S2052252514012585;
RA   Murray B., Antonyuk S.V., Marina A., Van Liempd S.M., Lu S.C.,
RA   Mato J.M., Hasnain S.S., Rojas A.L.;
RT   "Structure and function study of the complex that synthesizes S-
RT   adenosylmethionine.";
RL   IUCrJ 1:240-249(2014).
CC   -!- FUNCTION: Regulatory subunit of S-adenosylmethionine synthetase 2,
CC       an enzyme that catalyzes the formation of S-adenosylmethionine
CC       from methionine and ATP. Regulates MAT2A catalytic activity by
CC       changing its kinetic properties, increasing its affinity for L-
CC       methionine (PubMed:10644686, PubMed:23189196, PubMed:25075345).
CC       Can bind NADP (in vitro) (PubMed:23189196, PubMed:23425511).
CC       {ECO:0000269|PubMed:10644686, ECO:0000269|PubMed:23189196,
CC       ECO:0000269|PubMed:23425511, ECO:0000269|PubMed:25075345}.
CC   -!- PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine
CC       biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1.
CC       {ECO:0000269|PubMed:10644686, ECO:0000269|PubMed:23189196,
CC       ECO:0000269|PubMed:25075345}.
CC   -!- SUBUNIT: Heterotrimer; composed of a catalytic MAT2A homodimer
CC       that binds one regulatory MAT2B chain (PubMed:10644686,
CC       PubMed:23189196). Heterohexamer; composed of a central, catalytic
CC       MAT2A homotetramer flanked on either side by a regulatory MAT2B
CC       chain (PubMed:25075345). NADP binding increases the affinity for
CC       MAT2A (PubMed:23189196). {ECO:0000269|PubMed:10644686,
CC       ECO:0000269|PubMed:25075345, ECO:0000305|PubMed:23189196}.
CC   -!- INTERACTION:
CC       Q8IYQ9:KPNA3; NbExp=3; IntAct=EBI-10317491, EBI-742146;
CC       O00629:KPNA4; NbExp=3; IntAct=EBI-10317491, EBI-396343;
CC       P31153:MAT2A; NbExp=3; IntAct=EBI-10317491, EBI-1050743;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-10317491, EBI-719493;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NZL9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZL9-2; Sequence=VSP_025534;
CC       Name=3;
CC         IsoId=Q9NZL9-3; Sequence=VSP_025538, VSP_025539;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9NZL9-4; Sequence=VSP_025534, VSP_025540;
CC       Name=5;
CC         IsoId=Q9NZL9-5; Sequence=VSP_025535, VSP_025536, VSP_025537;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:10644686, ECO:0000269|PubMed:11337507}.
CC   -!- MISCELLANEOUS: Its expression in hepatoma cell lines may lead to
CC       increase DNA synthesis and thereby participate in cell
CC       proliferation.
CC   -!- SIMILARITY: Belongs to the dTDP-4-dehydrorhamnose reductase
CC       family. MAT2B subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG39296.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF182814; AAF28477.1; -; mRNA.
DR   EMBL; AJ243721; CAB56837.1; -; mRNA.
DR   EMBL; DQ395260; ABD59011.1; -; mRNA.
DR   EMBL; DQ413183; ABD85290.1; -; mRNA.
DR   EMBL; AL136664; CAB66599.1; -; mRNA.
DR   EMBL; AB073390; BAE45720.1; -; mRNA.
DR   EMBL; AY358695; AAQ89058.1; -; mRNA.
DR   EMBL; AK312365; BAG35283.1; -; mRNA.
DR   EMBL; CH471062; EAW61517.1; -; Genomic_DNA.
DR   EMBL; BC005218; AAH05218.1; -; mRNA.
DR   EMBL; BC066645; AAH66645.1; -; mRNA.
DR   EMBL; BC093030; AAH93030.1; -; mRNA.
DR   EMBL; AF113225; AAG39296.1; ALT_INIT; mRNA.
DR   CCDS; CCDS4364.1; -. [Q9NZL9-2]
DR   CCDS; CCDS4365.1; -. [Q9NZL9-1]
DR   RefSeq; NP_037415.1; NM_013283.4. [Q9NZL9-1]
DR   RefSeq; NP_877725.1; NM_182796.2. [Q9NZL9-2]
DR   UniGene; Hs.54642; -.
DR   PDB; 2YDX; X-ray; 2.80 A; A/B/C/D/E=28-334.
DR   PDB; 2YDY; X-ray; 2.25 A; A=28-334.
DR   PDB; 4KTT; X-ray; 2.59 A; E/F=22-334.
DR   PDB; 4KTV; X-ray; 3.30 A; E/F=22-334.
DR   PDB; 4NDN; X-ray; 2.34 A; E/F=22-334.
DR   PDBsum; 2YDX; -.
DR   PDBsum; 2YDY; -.
DR   PDBsum; 4KTT; -.
DR   PDBsum; 4KTV; -.
DR   PDBsum; 4NDN; -.
DR   ProteinModelPortal; Q9NZL9; -.
DR   SMR; Q9NZL9; -.
DR   BioGrid; 118166; 39.
DR   IntAct; Q9NZL9; 7.
DR   MINT; MINT-2819994; -.
DR   STRING; 9606.ENSP00000325425; -.
DR   DrugBank; DB00134; L-Methionine.
DR   iPTMnet; Q9NZL9; -.
DR   PhosphoSitePlus; Q9NZL9; -.
DR   SwissPalm; Q9NZL9; -.
DR   DMDM; 74719662; -.
DR   REPRODUCTION-2DPAGE; IPI00002324; -.
DR   EPD; Q9NZL9; -.
DR   MaxQB; Q9NZL9; -.
DR   PaxDb; Q9NZL9; -.
DR   PeptideAtlas; Q9NZL9; -.
DR   PRIDE; Q9NZL9; -.
DR   DNASU; 27430; -.
DR   Ensembl; ENST00000280969; ENSP00000280969; ENSG00000038274. [Q9NZL9-2]
DR   Ensembl; ENST00000321757; ENSP00000325425; ENSG00000038274. [Q9NZL9-1]
DR   Ensembl; ENST00000518095; ENSP00000428046; ENSG00000038274. [Q9NZL9-3]
DR   GeneID; 27430; -.
DR   KEGG; hsa:27430; -.
DR   UCSC; uc003lzj.5; human. [Q9NZL9-1]
DR   CTD; 27430; -.
DR   DisGeNET; 27430; -.
DR   GeneCards; MAT2B; -.
DR   HGNC; HGNC:6905; MAT2B.
DR   HPA; HPA037721; -.
DR   HPA; HPA037722; -.
DR   MIM; 605527; gene.
DR   neXtProt; NX_Q9NZL9; -.
DR   OpenTargets; ENSG00000038274; -.
DR   PharmGKB; PA30648; -.
DR   eggNOG; ENOG410IQ9F; Eukaryota.
DR   eggNOG; COG1091; LUCA.
DR   GeneTree; ENSGT00390000006721; -.
DR   HOVERGEN; HBG105851; -.
DR   InParanoid; Q9NZL9; -.
DR   KO; K00789; -.
DR   OMA; YKMDHYA; -.
DR   OrthoDB; EOG091G0AS1; -.
DR   PhylomeDB; Q9NZL9; -.
DR   TreeFam; TF332849; -.
DR   BRENDA; 2.5.1.6; 2681.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   UniPathway; UPA00315; UER00080.
DR   ChiTaRS; MAT2B; human.
DR   EvolutionaryTrace; Q9NZL9; -.
DR   GenomeRNAi; 27430; -.
DR   PRO; PR:Q9NZL9; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000038274; -.
DR   ExpressionAtlas; Q9NZL9; baseline and differential.
DR   Genevisible; Q9NZL9; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IC:UniProtKB.
DR   GO; GO:0048269; C:methionine adenosyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0048270; F:methionine adenosyltransferase regulator activity; IDA:UniProtKB.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006556; P:S-adenosylmethionine biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR005913; dTDP_dehydrorham_reduct.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR029903; RmlD-like-bd.
DR   PANTHER; PTHR10491; PTHR10491; 1.
DR   Pfam; PF04321; RmlD_sub_bind; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; NADP; One-carbon metabolism;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:10644686}.
FT   CHAIN         2    334       Methionine adenosyltransferase 2 subunit
FT                                beta.
FT                                /FTId=PRO_0000287520.
FT   NP_BIND      37     40       NADP. {ECO:0000244|PDB:2YDX}.
FT   NP_BIND      60     62       NADP. {ECO:0000244|PDB:2YDX}.
FT   NP_BIND      71     72       NADP. {ECO:0000244|PDB:2YDX}.
FT   REGION      319    334       Required for interaction with MAT2A.
FT                                {ECO:0000269|PubMed:25075345}.
FT   BINDING      93     93       NADP; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:2YDX}.
FT   BINDING      97     97       NADP. {ECO:0000244|PDB:2YDX}.
FT   BINDING     159    159       NADP. {ECO:0000244|PDB:2YDX}.
FT   BINDING     185    185       NADP; via amide nitrogen.
FT                                {ECO:0000244|PDB:2YDX}.
FT   MOD_RES     309    309       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     21       MVGREKELSIHFVPGSCRLVE -> MPEMPEDMEQ (in
FT                                isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2, ECO:0000303|Ref.3}.
FT                                /FTId=VSP_025534.
FT   VAR_SEQ       1     20       MVGREKELSIHFVPGSCRLV -> MPEMPEDMEQ (in
FT                                isoform 5). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_025535.
FT   VAR_SEQ      87     93       PHVIVHC -> VLLTALS (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_025536.
FT   VAR_SEQ      94    334       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_025537.
FT   VAR_SEQ     241    259       DPSIKGTFHWSGNEQMTKY -> VRRIPESCLSEGPLCLFH
FT                                A (in isoform 3).
FT                                {ECO:0000303|PubMed:12880961}.
FT                                /FTId=VSP_025538.
FT   VAR_SEQ     260    334       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12880961}.
FT                                /FTId=VSP_025539.
FT   VAR_SEQ     279    295       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_025540.
FT   VARIANT     293    293       A -> T (in dbSNP:rs17849948).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032318.
FT   CONFLICT    150    150       E -> G (in Ref. 9; AAH93030).
FT                                {ECO:0000305}.
FT   CONFLICT    302    302       T -> I (in Ref. 9; AAH66645).
FT                                {ECO:0000305}.
FT   STRAND       30     34       {ECO:0000244|PDB:2YDY}.
FT   TURN         35     37       {ECO:0000244|PDB:2YDY}.
FT   HELIX        39     49       {ECO:0000244|PDB:2YDY}.
FT   TURN         50     52       {ECO:0000244|PDB:2YDY}.
FT   STRAND       54     58       {ECO:0000244|PDB:2YDY}.
FT   TURN         60     62       {ECO:0000244|PDB:4KTV}.
FT   TURN         64     66       {ECO:0000244|PDB:4NDN}.
FT   STRAND       67     69       {ECO:0000244|PDB:4NDN}.
FT   HELIX        79     85       {ECO:0000244|PDB:2YDY}.
FT   STRAND       88     92       {ECO:0000244|PDB:2YDY}.
FT   HELIX        99    104       {ECO:0000244|PDB:4NDN}.
FT   HELIX       106    113       {ECO:0000244|PDB:4NDN}.
FT   HELIX       115    126       {ECO:0000244|PDB:2YDY}.
FT   STRAND      130    136       {ECO:0000244|PDB:2YDY}.
FT   HELIX       137    139       {ECO:0000244|PDB:2YDY}.
FT   STRAND      142    144       {ECO:0000244|PDB:2YDY}.
FT   HELIX       158    173       {ECO:0000244|PDB:2YDY}.
FT   STRAND      178    182       {ECO:0000244|PDB:2YDY}.
FT   STRAND      184    186       {ECO:0000244|PDB:2YDY}.
FT   HELIX       192    194       {ECO:0000244|PDB:2YDY}.
FT   HELIX       198    200       {ECO:0000244|PDB:2YDY}.
FT   HELIX       201    205       {ECO:0000244|PDB:2YDY}.
FT   STRAND      207    209       {ECO:0000244|PDB:4KTV}.
FT   STRAND      211    214       {ECO:0000244|PDB:2YDY}.
FT   STRAND      216    219       {ECO:0000244|PDB:2YDY}.
FT   HELIX       224    239       {ECO:0000244|PDB:2YDY}.
FT   STRAND      246    249       {ECO:0000244|PDB:2YDY}.
FT   HELIX       258    268       {ECO:0000244|PDB:2YDY}.
FT   STRAND      276    279       {ECO:0000244|PDB:2YDY}.
FT   STRAND      285    287       {ECO:0000244|PDB:2YDY}.
FT   HELIX       298    302       {ECO:0000244|PDB:2YDY}.
FT   HELIX       311    319       {ECO:0000244|PDB:2YDY}.
FT   HELIX       320    322       {ECO:0000244|PDB:2YDY}.
FT   HELIX       324    327       {ECO:0000244|PDB:4NDN}.
FT   TURN        330    333       {ECO:0000244|PDB:2YDX}.
SQ   SEQUENCE   334 AA;  37552 MW;  6AAA5381BAF3F65F CRC64;
     MVGREKELSI HFVPGSCRLV EEEVNIPNRR VLVTGATGLL GRAVHKEFQQ NNWHAVGCGF
     RRARPKFEQV NLLDSNAVHH IIHDFQPHVI VHCAAERRPD VVENQPDAAS QLNVDASGNL
     AKEAAAVGAF LIYISSDYVF DGTNPPYREE DIPAPLNLYG KTKLDGEKAV LENNLGAAVL
     RIPILYGEVE KLEESAVTVM FDKVQFSNKS ANMDHWQQRF PTHVKDVATV CRQLAEKRML
     DPSIKGTFHW SGNEQMTKYE MACAIADAFN LPSSHLRPIT DSPVLGAQRP RNAQLDCSKL
     ETLGIGQRTP FRIGIKESLW PFLIDKRWRQ TVFH
//
